Wells Fargo Maintains a Buy on Elevance Health (ELV), Sets a $478 PT

Elevance Health, Inc. (NYSE:ELV) is one of the 10 Cheap Large Cap Stocks to Buy According to Hedge FundsOn June 18, Wells Fargo analyst Stephen Baxter maintained a Buy rating on Elevance Health, Inc. (NYSE:ELV) and set a price target of $478.00.

Is Elevance Health, Inc. (ELV) The Top Falling Stock with Unusual Volume?

A medical professional working at a computer, utilizing the company’s digital solutions to improve care quality for consumers.

The company reported positive fiscal Q1 2025 results, with operating revenue for the quarter reaching $48.8 billion, up 15.4% from fiscal Q1 2024. Elevance Health, Inc. (NYSE:ELV) also reported $3.3 billion in adjusted operating gains, reflecting a 4.1% growth compared to the same period last year.

Elevance Health, Inc. (NYSE:ELV) offers telehealth services to its customers, reporting in 2024 that the company conducted more than 800,000 virtual visits in 2023. This health company operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other.

The Health Benefits segment offers a range of health plans and services, while the CarelonRx segment manages pharmacy services. The Carelon Services segment offers various healthcare-related services by integrating behavioral, physical, pharmacy, and social services.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.